Mark L. Brantly, MD
Emeritus Professor of Medicine
Email: mark.brantly@medicine.ufl.edu
TEL: 352-273-8737
Degree/Program |
Institution |
Field/Specialty |
| MD | University of Florida College of Medicine | |
| Residency | Eastern Virginia Medical School | Internal Medicine |
| Fellowship | National Institute of Health, Bethesda, MD | Pulmonary Disease & Critical Care |
Clinical Interests:
- Alpha-1 Antitrypsin Deficiency
- Alpha-1 Antitrypsin Test
- Chronic Obstructive Pulmonary Disease
Research Interests:
- Role of Inflammation in Alpha-1 Antitrypsin Deficiency
- Chronic Obstructive Pulmonary Disease
Professional Societies:
- American Thoracic Association
- American Society of Cell Biology
Honors and Awards:
- 1995 Alpha1 National Association Award
- 1998 Alpha1 Foundation Research Professorship
Publications (2004 onwards):
- M. Brantly, J. Wittes, C. Vogelmeier, R. Hubbard, G. Fells, and R. Crystal. Use of a Highly Purified a1-Antitrypsin Standard to Establish Ranges for the Common Normal and Deficient a1-Antitrypsin Phenotypes. Chest 1991 Sept;100:703-708.
- Flotte TR, Brantly ML, Spencer LT, Byrne BJ, Spencer CT, Baker DJ, Humphries M. Phase I trial of intramuscular injection of a recombinant adeno-associated virus alpha 1-antitrypsin (rAAV2-CB-hAAT) gene vector to AAT-deficient adults. Human Gene Therapy 2004 Jan; 15:93-128.
- Strange, C., Dickson, R., Carter, C., Carpenter, M.J., Holladay, B., Lundquist, R., Brantly, M.L. Genetic Testing for Alpha1-Antitrypsin Deficiency. Genetic Testing for Alpha1-Antitrypsin Deficiency. In press Genetics in Medicine 2004.
For a complete list of the publications,
Visit Pubmed, US National Library of Medicine (NLM)
Patents:
Increased Expression of Alpha-1-Antitrypsin in Expression Vectors through the inclusion of Intron II. Patent Serial Number 08/060,925
Please click here for a list of Dr. Brantly’s industry relationships.